Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: Implications for immunotherapy

Archives of Dermatological Research

Volumn 295, Issue 4, 2003, Pages 146-154

  Kurzen, Hjalmar ^a   Kaul, Sepp ^a   Egner, Ursel ^a   Deichmann, Martin ^a   Hartschuh, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer; Glycoprotein; Neuroendocrine; Skin; Tumor marker

Indexed keywords

CELL ADHESION MOLECULE; EPITHELIAL CELL ADHESION MOLECULE; GLYCOPROTEIN; MONOCLONAL ANTIBODY; MUCIN 1; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; DISEASE COURSE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MERKEL CELL TUMOR; METASTASIS; NEVUS; PRIORITY JOURNAL; SEBACEOUS GLAND; SKIN CARCINOMA;

ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CARCINOMA, MERKEL CELL; CELL ADHESION MOLECULES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MEMBRANE PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0042878669     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-003-0410-y     Document Type: Article

References (52)

1. Baeckstrom D, Nilsson O, Price MR, Lindholm L, Hansson GC (1993) Discrimination of MUC1 mucins from other sialyl-Le(a)-carrying glycoproteins produced by colon carcinoma cells using a novel monoclonal antibody. Cancer Res 53:755-761
2. Balzar M, Winter MJ, de Boer CJ, Litvinov SV (1999) The biology of the 17-1A antigen (Ep-CAM). J Mol Med 77:699-712
3. Beer TW, Shepherd P, Theaker JM (2000) Ber EP4 and epithelial membrane antigen aid distinction of basal cell, squamous cell and basosquamous carcinomas of the skin. Histopathology 37:218-223
4. Burchell J, Taylor-Papadimitriou J (1993) Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product. Epithelial Cell Biol 2:155-162
5. Cheung KL, Graves CR, Robertson JF (2000) Tumour marker measurements in the diagnosis and monitoring of breast cancer. Cancer Treat Rev 26:91-102
6. Croce MV, Rabassa ME, Price MR, Segal-Eiras A (2001) MUC1 mucin and carbohydrate associated antigens as tumor markers in head and neck squamous cell carcinoma. Pathol Oncol Res 7:284-291
7. Dion AS, Smorodinsky NI, Williams CJ, Wreschner DH, Major PP, Keydar I (1991) Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies. Hybridoma 10:595-610
8. Fricker J (1997) Mucin-based vaccines and cancer. Mol Med Today 3:47
9. Gould E, Albores-Saavedra J, Dubner B, Smith W, Payne CM (1988) Eccrine and squamous differentiation in Merkel cell carcinoma. An immunohistochemical study. Am J Surg Pathol 12:768-772
10. Han AC, Soler AP, Tang CK, Knudsen KA, Salazar H (2000) Nuclear localization of E-cadherin expression in Merkel cell carcinoma. Arch Pathol Lab Med 124:1147-1151
11. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57-70
12. Hartschuh W, Grube D (1979) The Merkel cell - a member of the APUD cell system. Fluorescence and electron microscopic contribution to the neurotransmitter function of the Merkel cell granules. Arch Dermatol Res 265:115-122
13. Hartschuh W, Weihe E, Egner U (1989) Chromogranin A in the mammalian Merkel cell: cellular and subcellular distribution. J Invest Dermatol 93:641-648
14. Hilkens J, Wesseling J, Vos HL, Storm J, Boer M, van der Valk SW (1995) Episialin/CA15-3: its structure and involvement in breast cancer progression. Ned Tijdschr Klein Chem 20:293-298
15. Holmberg LA, Sandmaier BM (2001) Theratope vaccine (STn-KLH). Expert Opin Biol Ther 1:881-891
16. Holmberg LA, Oparin DV, Gooley T, Lilleby K, Bensinger W, Reddish MA, MacLean GD, Longenecker BM, Sandmaier BM (2000) Clinical outcome of breast and ovarian cancer patients treated with high-dose chemotherapy, autologous stem cell rescue and THERATOPE STn-KLH cancer vaccine. Bone Marrow Transplant 25:1233-1241
17. Kaul S, Windecker S, Bastert G (1989) Monoclonal antibodies reactive with tumor-associated epitopes of breast mucin glycoproteins. Proc Am Assoc Cancer Res 30:349
18. Koprowski H, Steplewski Z, Mitchel K, Herlyn M, Herlyn D, Fuhrer P (1979) Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 5:957-963
19. Kurzen H, Esposito L, Langbein L, Hartschuh W (2001) Cytokeratins as markers of follicular differentiation: an immunohistochemical study of trichoblastoma and basal cell carcinoma. Am J Dermatopathol 23:501-509
20. Layfield L, Ulich T, Liao S, Barr R, Cheng L, Lewin KL (1986) Neuroendocrine carcinoma of the skin: an immunohistochemical study of tumor markers and neuroendocrine products. J Cutan Pathol 13:268-273
21. Litvinov SV, van Driel W, van Rhijn CM, Bakker HAM, van Krieken H, Fleuren GJ, Warnaar SO (1996) Expression of Ep-CAM in cervical squamous epithelia correlates with an increased proliferation and the disappearance of markers for terminal differentiation. Am J Pathol 148:865-875
22. Lloyd KO, Burchell J, Kudryashov V, Yin BW, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC-1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells. J Biol Chem 271:33325-33334
23. LoBuglio AF, Saleh MN (1992) Advances in monoclonal antibody therapy of cancer. Am J Med Sci 304:214-224
24. Moll I, Moll R (1992) Early development of human Merkel cells. Exp Dermatol 1:180-184
25. Morse MA (2001) Technology evaluation: BLP-25, Biomira Inc. Curr Opin Mol Ther 3:102-105
26. Mount SL, Taatjes DJ (1994) Neuroendocrine carcinoma of the skin (Merkel cell carcinoma). An immunoelectron-microscopic case study. Am J Dermatopathol 16:60-65
27. Nitta T, Sugihara K, Tsuyama S, Murata F (2000) Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis. Cancer 88:245-254
28. Ortonne JP, Petchot-Bacque JP, Verrando P, Pisani A, Pautrat G, Bernerd F (1988) Normal Merkel cells express a synaptophysin-like immunoreactivity. Dermatologica 177:1-10
29. Patton ST, Gendler SJ, Spicer AP (1995) Heterogeneity in production, secretion and glycosylation of MUC1 epithelial mucin by primary cultures of ovarian carcinoma. Int J Cancer 63:412-418
30. Perrin C, Pisani A, Demarchez M, Michiel JF, Ortonne JP (1996) Vla and alpha 6 beta 4 integrin expression in neuroendocrine carcinomas of the skin (their xenografts on nude mice and a corresponding primary culture). J Cutan Pathol 23:223-228
31. Petersen OW, van Deurs B (1986) Characterization of epithelial membrane antigen expression in human mammary epithelium by ultrastructural immunoperoxidase cytochemistry. J Histochem Cytochem 34:801-809
32. Punt CJ, Nagy A, Douillard JY, Figer A, Skovsgaard T, Monson J, Barone C, Fountzilas G, Riess H, Moylan E, Jones D, Dethling J, Colman J, Coward L, MacGregor S (2002) Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study. Lancet 360:671-677
33. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997a) GeneCards: encyclopedia for genes, proteins and diseases (GeneCard for MUC1). Bioinformatics Unit and Genome Center, Weizmann Institute of Science, Rehovot, Israel
34. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D (1997b) GeneCards: encyclopedia for genes, proteins and diseases (GeneCard for TACSTD-1). Bioinformatics Unit and Genome Center, Weizmann Institute of Science, Rehovot, Israel
35. Reis CA, David L, Seixas M, Burchell J, Sobrinho-Simoes M (1998) Expression of fully and under-glycosylated forms of MUC1 mucin in gastric carcinoma. Int J Cancer 79:402-410
36. Riethmuller G, Holz E, Schlimok G, Schmiegel W, Raab R, Hoffken K, Gruber R, Funke I, Pichlmaier H, Hirche H, Buggisch P, Witte J, Pichlmayr R (1998) Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial. J Clin Oncol 16:1788-1794
37. Rye PD, Bovin NV, Vlasova EV, Molodyk AA, Baryshnikov A, Kreutz FT, Garinther WI, Schultes BC, Noujaim AA, Madiyalakan R, Magnani J, Nilsson O, Nilsson K, Nustad K, Norum L, Bell H, Cao Y, Suresh MR, Very DL, Freeman JV, Yeung KK, Hilgers J (1998) Summary report on the ISOBM TD-6 workshop: analysis of 20 monoclonal antibodies against Sialyl Lewisa and related antigens. Montreux, Switzerland, 19-24 September 1997. Tumour Biol 19:390-420
38. Ryuko K, Schol DJ, Snijdewint FG, von Mensdorff-Pouilly S, Poort-Keesom RJ, Karuntu-Wanamarta YA, Verstraeten RA, Miyazaki K, Kenemans P, Hilgers J (2000) Characterization of a new MUC1 monoclonal antibody (VU-2-G7) directed to the glycosylated PDTR sequence of MUC1. Tumour Biol 21:197-210
39. Schulz T, Hartschuh W (1995) Merkel cells in nevus sebaceous. An immunohistochemical study. Am J Dermatopathol 17:570-579
40. Schumacher U, Adam E (1998) Immunohistochemical detection of MUC1 gene product in human cancers grown in scid mice. J Histochem Cytochem 46:127-134
41. Smith KJ, Skelton HG 3rd, Holland TT, Morgan AM, Lupton GP (1993) Neuroendocrine (Merkel cell) carcinoma with an intraepidermal component. Am J Dermatopathol 15:528-533
42. Strous GJ, Dekker J (1992) Mucin-type glycoproteins. Crit Rev Biochem Mol Biol 27:57-92
43. Szeder V, Grim M, Halata Z, Sieber-Bluma M (2003) Neural crest origin of mammalian Merkel cells. Dev Biol 253:258-263
44. Tatemoto Y, Saka M, Tanimura T, Mori M (1987) Immunohistochemical observations on binding of monoclonal antibody to epithelial membrane antigen in epithelial tumors of the oral cavity and skin. Oral Surg Oral Med Oral Pathol 64:721-726
45. Taylor-Papadimitriou J, Epenetos AA (1994) Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol 12:227-233
46. Tellechea O, Reis JP, Domingues JC, Baptista AP (1993) Monoclonal antibody Ber EP4 distinguishes basal-cell carcinoma from squamous-cell carcinoma of the skin. Am J Dermatopathol 15:452-455
47. Tsubura A, Senzaki H, Sasaki M, Hilgers J, Morii S (1992) Immunohistochemical demonstration of breast-derived and/or carcinoma-associated glycoproteins in normal skin appendages and their tumors. J Cutan Pathol 19:73-79
48. Yamamoto M, Bharti A, Li Y, Kufe D (1997) Interaction of the DF3/MUC1 breast carcinoma-associated antigen and beta-catenin in cell adhesion. J Biol Chem 272:12492-12494
49. Wesseling J, van der Valk SW, Vos HL, Sonnenberg A, Hilkens A (1995) Episialin (MUC1) overexpression inhibits integrin mediated cell adhesion to extracellular matrix components. J Cell Biol 129:255-265
50. White CA, Weaver RL, Grillo-Lopez AJ (2001) Antibody-targeted immunotherapy for treatment of malignancy. Annu Rev Med 52:125-145
51. Wick MR, Kaye VN, Sibley RK, Tyler R, Frizzera G (1986) Primary neuroendocrine carcinoma and small-cell malignant lymphoma of the skin. A discriminant immunohistochemical comparison. J Cutan Pathol 13:347-358
52. Xu Y, Kimura N, Yoshida R, Lin H, Yoshinaga K (2001) Immunohistochemical study of Muc1, Muc2 and human gastric mucin in breast carcinoma: relationship with prognostic factors. Oncol Rep 8:1177-1182